This NDC is on FDA's drug shortage list (posted Feb 8, 2019)
Product Information
DEXAMETHASONE 20 MG/5 ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $0.2381 per ML under NDC 63323016505. Its NADAC has been published 380 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
4 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323016505
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
3/18/2026
Active Ingredients
DEXAMETHASONE SODIUM PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA084916FDA Approved
Before 1982
TE Code
AP
On Market Since
9/7/2000
Pharmacological Classes
Price Statistics
The NADAC for DEXAMETHASONE 20 MG/5 ML VIAL has been published 380 times since Nov 28, 2013, and over the history we have for it it has declined 43.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2381 per ML |
|---|---|
| All-time high | $0.5687 (Dec 16, 2015) |
| All-time low | $0.1463 (Oct 18, 2017) |
| 52-week high | $0.2381 |
| 52-week low | $0.1559 |
| Median price | $0.2654 |
| Average price | $0.3231 |
| Largest weekly change | -72.8% (Oct 18, 2017) |
| Weeks tracked | 380 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DEXAMETHASONE SODIUM PHOSPHATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXAMETHASONE 20 MG/5 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for DEXAMETHASONE 20 MG/5 ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $0.2381 per ML (NDC 63323016505), effective Sep 30, 2026.
How has the price of DEXAMETHASONE 20 MG/5 ML VIAL changed over time?
Over the history we have for it, the NADAC for DEXAMETHASONE 20 MG/5 ML VIAL has declined 43.2%. It has been tracked across 380 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DEXAMETHASONE 20 MG/5 ML VIAL?
Since Nov 28, 2013, the NADAC for DEXAMETHASONE 20 MG/5 ML VIAL has ranged from a low of $0.1463 (Oct 18, 2017) to a high of $0.5687 (Dec 16, 2015), with a median of $0.2654 per ML.
Are there cheaper alternatives to DEXAMETHASONE 20 MG/5 ML VIAL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXAMETHASONE 20 MG/5 ML VIAL, is $0.1807 per ML — about 24% below DEXAMETHASONE 20 MG/5 ML VIAL.
Who manufactures DEXAMETHASONE 20 MG/5 ML VIAL?
DEXAMETHASONE 20 MG/5 ML VIAL (NDC 63323016505) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.
Is DEXAMETHASONE 20 MG/5 ML VIAL in shortage?
Yes — NDC 63323016505 is currently listed in FDA's drug shortage database (posted Feb 8, 2019).